Sisram Medical (HKG:1696) plans to repurchase up to 1% of its issued shares in the open market from time to time, subject to market conditions, according to a Thursday Hong Kong bourse filing.
The company said will decide whether to cancel the repurchased shares or hold them as treasury shares based on its capital management needs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.